Company intelligence / Profile preview

Medochemie

Limassol, Limassol, Cyprusmedochemie.com ↗

Ownership: Private
Employees: ~2000
Development stage: Other

Overview

Medochemie is a leading European manufacturer of branded generics with over 5,000 marketing authorizations for 630 different pharmaceutical products across more than 10 therapeutic areas. The company operates at commercial scale with global distribution in over 120 countries. It plays a key role in the EU Critical Medicines Alliance by supplying essential medicines for public health needs including antimicrobials critical to fighting resistance.

Therapeutic areas: NeurologyInfectious DiseasesHematologyMen's HealthCardiovascular
Modalities: Small molecule
Industry: Biotech

Partnerships

Medicines for EuropeEU Critical Medicines Alliance

Beyond the preview

Go deeper on Medochemie.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medochemie.

Explore the full profile